Bicara Therapeutics BCAX Short- and long-term operating lease liabilities
Short- and long-term operating lease liabilities at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's short- and long-term operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's short- and long-term operating lease liabilities?
- Bicara Therapeutics (BCAX) reported short- and long-term operating lease liabilities of -$270K in Q1 2026.
- How has Bicara Therapeutics's short- and long-term operating lease liabilities changed year-over-year?
- Bicara Therapeutics's short- and long-term operating lease liabilities decreased by 83.7% year-over-year, from -$147K to -$270K.
- What does short- and long-term operating lease liabilities mean?
- Measures the net change in the company's obligations related to operating leases for office or laboratory space. Monitoring this helps investors understand the company's long-term fixed facility commitments and their impact on future cash flow requirements.